Dogwood Therapeutics's three largest insider shareholders as of September 09, 2026 are Ltd Sealbond (Director, 24.66Mn shares), Ltd Sealbond (Director, 24.66Mn shares), Angela Walsh (Svp Of Finance, 3.00K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Ltd Sealbond | Director, TenPercentOwner, Other | 21,822,333 | 2,842,638 | 24,664,971 | 100.0% | 25 Nov, 2025 |
| 2 | Angela Walsh | Svp Of Finance | 0 | 3,000 | 3,000 | 0.0% | 24 May, 2022 |
| 3 | Gregory Scott Duncan | Chief Executive Officer | 2,298 | 0 | 2,298 | 0.0% | 18 Aug, 2023 |
| 4 | William Pridgen | Director | 0 | 2,082 | 2,082 | 0.0% | 22 Aug, 2023 |
| 5 | David R Keefer | Director | 200 | 0 | 200 | 0.0% | 05 Jan, 2022 |
| 6 | La Rosa Abel De | Director | 160 | 0 | 160 | 0.0% | 07 Jan, 2022 |
| 7 | John C Thomas | Director | 40 | 0 | 40 | 0.0% | 04 Jan, 2022 |
| 8 | Richard James Whitley | Director | 28 | 0 | 28 | 0.0% | 12 Dec, 2022 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 16 Jun, 2026 | Richard James Whitley | Director | Acquired A | 16,800 | $0.00 | $0 | 16,800 | Direct |
| 16 Jun, 2026 | David R Keefer | Director | Acquired A | 16,800 | $0.00 | $0 | 16,800 | Direct |
| 16 Jun, 2026 | John C Thomas | Director | Acquired A | 16,800 | $0.00 | $0 | 16,800 | Direct |
| 16 Jun, 2026 | La Rosa Abel De | Director | Acquired A | 16,800 | $0.00 | $0 | 16,800 | Direct |
| 05 Mar, 2026 | Gregory Scott Duncan | Chief Executive Officer | Acquired A | 330,000 | $0.00 | $0 | 330,000 | Direct |
| 05 Mar, 2026 | Ralph Grosswald | Svp Of Operations | Acquired A | 82,500 | $0.00 | $0 | 82,500 | Direct |
| 05 Mar, 2026 | Angela Walsh | Chief Financial Officer | Acquired A | 82,500 | $0.00 | $0 | 82,500 | Direct |
| 05 Mar, 2026 | Roger Michael Gendreau | Chief Medical Officer | Acquired A | 82,500 | $0.00 | $0 | 82,500 | Direct |
| 05 Mar, 2026 | Angela Walsh | Chief Financial Officer | Acquired A | 82,500 | $0.00 | $0 | 82,500 | Direct |
| 05 Mar, 2026 | Angela Walsh | Chief Financial Officer | Acquired A | 82,500 | $0.00 | $0 | 82,500 | Direct |
| 05 Mar, 2026 | Angela Walsh | Chief Financial Officer | Acquired A | 82,500 | $0.00 | $0 | 82,500 | Direct |
| 04 Dec, 2025 | Angela Walsh | Chief Financial Officer | Acquired A | 150,000 | $0.00 | $0 | 150,000 | Direct |
| 04 Dec, 2025 | Angela Walsh | Chief Financial Officer | Acquired A | 150,000 | $0.00 | $0 | 150,000 | Direct |
| 04 Dec, 2025 | Gregory Scott Duncan | Chief Executive Officer | Acquired A | 460,000 | $0.00 | $0 | 460,000 | Direct |
| 04 Dec, 2025 | Angela Walsh | Chief Financial Officer | Acquired A | 150,000 | $0.00 | $0 | 150,000 | Direct |
| 04 Dec, 2025 | Ralph Grosswald | Svp Of Operations | Acquired A | 150,000 | $0.00 | $0 | 150,000 | Direct |
| 04 Dec, 2025 | Angela Walsh | Chief Financial Officer | Acquired A | 150,000 | $0.00 | $0 | 150,000 | Direct |
| 04 Dec, 2025 | Roger Michael Gendreau | Chief Medical Officer | Acquired A | 150,000 | $0.00 | $0 | 150,000 | Direct |
| 21 Nov, 2025 | Ltd Sealbond | Director, TenPercentOwner, Other | Acquired C | 21,610,950 | — | — | 21,822,333 | Direct |
| 21 Nov, 2025 | Ltd Sealbond | Director, TenPercentOwner, Other | Acquired C | 21,610,950 | — | — | 21,822,333 | Direct |